Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Automera logo — Empowering the next evolution in degradation platforms.

Automera

Empowering the next evolution in degradation platforms.

Founded 2022 Singapore Singapore 10 employees Series A Total: $16.00M Biotechnology, Health and Wellness

General Information

Company Name Automera
Founded Year 2022
Location Singapore Singapore +2
Employees 10
Industries Biotechnology, Health and Wellness
Funding Stage Series A
Social

Get notified when Automera moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Automera

Automera is an early-stage biotechnology company founded in 2022 in Singapore. The company's mission is to develop a groundbreaking therapeutic approach through autophagy-based targeted protein degradation. Automera sets itself apart by combining its deep understanding of autophagy with advanced drug development capabilities, as well as access to quantum chemistry and generative AI-enabled insights to drive its drug development programs. One of the key highlights of Automera is its AUTAC platform, which exhibits significant potential across a wide range of diseases, with a primary focus on oncology as its lead program. The company's commitment to leveraging cutting-edge technologies positions it as an innovative player in the biotech space. On 27 September 2023, Automera secured a notable $16.00M Series A investment from prominent backers including EDBI, Accelerator Corp., Xora Innovation, and ClavystBio. This investment reflects the confidence of industry players in Automera's potential to revolutionize targeted protein degradation and make a meaningful impact in the field of therapeutics.

Taxonomy: biotech, drug development, therapeutic approach, autophagy, protein degradation, oncology, cancer, disease areas, quantum chemistry, AI-enabled insights, Talo Labs Pte Ltd, early-stage, AUTAC platform, founder-led

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Series A •••••• 4
Investor Investor Investor Investor
27 Sep 2023

Automera Alternatives & Competitors

Automera vs
PAQ Therapeutics
PAQ Therapeutics United States

Pioneering a new approach to restoring health and curing disease through autophagy

Series B
12 employees
Biotechnology, Health Care
Automera vs
Oncolix
Oncolix

Pioneering new horizons in ovarian cancer treatment with a focus on autophagy through our innovative...

Series Unknown
0-1 employees
Biotechnology, Health Care
Automera vs
AutoPhagyGO
AutoPhagyGO

Pioneering autophagy solutions for a healthier, longer life.

Series Unknown
Biotechnology, Health Care

FAQ About Automera

Empowering the next evolution in degradation platforms.
Automera was founded in 2022.
Automera is headquartered in Singapore.
Automera operates in the following industries: Biotechnology, Health and Wellness.
Automera has approximately 10 employees.
Automera has completed 1 funding round, raising a total of $16.00M. The latest funding stage is Series A.
Top alternatives and competitors to Automera include PAQ Therapeutics, Oncolix, AutoPhagyGO, Nine Square Therapeutics, AbilityPharma. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Automera and PAQ Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Automera and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy